|
|
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
38-1794485
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer Identification No.)
|
17450 College Parkway,
|
Livonia,
|
Michigan
|
48152
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
Common Stock, $1.00 par value
|
MAS
|
New York Stock Exchange
|
Large accelerated filer
|
☒
|
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
|
Smaller reporting company
|
☐
|
|
|
|
Emerging growth company
|
☐
|
Class
|
|
Shares Outstanding at March 31, 2020
|
Common stock, par value $1.00 per share
|
|
263,755,373
|
|
|
|
|
|
|
|
|
Page No.
|
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||
ASSETS
|
|
|
|
|
|
||
Current Assets:
|
|
|
|
|
|
||
Cash and cash investments
|
$
|
767
|
|
|
$
|
697
|
|
Receivables
|
1,142
|
|
|
997
|
|
||
Prepaid expenses and other
|
80
|
|
|
90
|
|
||
Assets held for sale
|
—
|
|
|
173
|
|
||
Inventories:
|
|
|
|
|
|
||
Finished goods
|
487
|
|
|
485
|
|
||
Raw material
|
205
|
|
|
211
|
|
||
Work in process
|
64
|
|
|
58
|
|
||
|
756
|
|
|
754
|
|
||
Total current assets
|
2,745
|
|
|
2,711
|
|
||
Property and equipment, net
|
861
|
|
|
878
|
|
||
Operating lease right-of-use assets
|
171
|
|
|
176
|
|
||
Goodwill
|
518
|
|
|
509
|
|
||
Other intangible assets, net
|
264
|
|
|
259
|
|
||
Other assets
|
281
|
|
|
139
|
|
||
Assets held for sale
|
—
|
|
|
355
|
|
||
Total assets
|
$
|
4,840
|
|
|
$
|
5,027
|
|
|
|
|
|
||||
LIABILITIES
|
|
|
|
|
|
||
Current Liabilities:
|
|
|
|
|
|
||
Accounts payable
|
$
|
743
|
|
|
$
|
697
|
|
Notes payable
|
5
|
|
|
2
|
|
||
Accrued liabilities
|
756
|
|
|
700
|
|
||
Liabilities held for sale
|
—
|
|
|
149
|
|
||
Total current liabilities
|
1,504
|
|
|
1,548
|
|
||
Long-term debt
|
2,771
|
|
|
2,771
|
|
||
Noncurrent operating lease liabilities
|
157
|
|
|
162
|
|
||
Other liabilities
|
573
|
|
|
589
|
|
||
Liabilities held for sale
|
—
|
|
|
13
|
|
||
Total liabilities
|
5,005
|
|
|
5,083
|
|
||
|
|
|
|
||||
Commitments and contingencies (Note P)
|
|
|
|
|
|
||
|
|
|
|
||||
EQUITY
|
|
|
|
|
|
||
Masco Corporation's shareholders' equity:
|
|
|
|
|
|
||
Common shares, par value $1 per share
Authorized shares: 1,400,000,000;
Issued and outstanding: 2020 – 262,600,000; 2019 – 275,600,000
|
263
|
|
|
276
|
|
||
Preferred shares authorized: 1,000,000;
Issued and outstanding: 2020 and 2019 – None
|
—
|
|
|
—
|
|
||
Paid-in capital
|
—
|
|
|
—
|
|
||
Retained deficit
|
(412
|
)
|
|
(332
|
)
|
||
Accumulated other comprehensive loss
|
(199
|
)
|
|
(179
|
)
|
||
Total Masco Corporation's shareholders' deficit
|
(348
|
)
|
|
(235
|
)
|
||
Noncontrolling interest
|
183
|
|
|
179
|
|
||
Total equity
|
(165
|
)
|
|
(56
|
)
|
||
Total liabilities and equity
|
$
|
4,840
|
|
|
$
|
5,027
|
|
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Net sales
|
$
|
1,581
|
|
|
$
|
1,513
|
|
Cost of sales
|
1,034
|
|
|
991
|
|
||
Gross profit
|
547
|
|
|
522
|
|
||
Selling, general and administrative expenses
|
322
|
|
|
316
|
|
||
Impairment charge for other intangible assets
|
—
|
|
|
9
|
|
||
Operating profit
|
225
|
|
|
197
|
|
||
Other income (expense), net:
|
|
|
|
|
|
||
Interest expense
|
(35
|
)
|
|
(39
|
)
|
||
Other, net
|
(16
|
)
|
|
(5
|
)
|
||
|
(51
|
)
|
|
(44
|
)
|
||
Income from continuing operations before income taxes
|
174
|
|
|
153
|
|
||
Income tax expense
|
33
|
|
|
35
|
|
||
Income from continuing operations
|
141
|
|
|
118
|
|
||
Income from discontinued operations, net
|
397
|
|
|
9
|
|
||
Net income
|
538
|
|
|
127
|
|
||
Less: Net income attributable to noncontrolling interest
|
8
|
|
|
11
|
|
||
Net income attributable to Masco Corporation
|
$
|
530
|
|
|
$
|
116
|
|
|
|
|
|
||||
Income per common share attributable to Masco Corporation:
|
|
|
|
|
|
||
Basic:
|
|
|
|
|
|
||
Income from continuing operations
|
$
|
.49
|
|
|
$
|
.36
|
|
Income from discontinued operations, net
|
1.44
|
|
|
.03
|
|
||
Net income
|
$
|
1.93
|
|
|
$
|
.39
|
|
Diluted:
|
|
|
|
|
|
||
Income from continuing operations
|
$
|
.48
|
|
|
$
|
.36
|
|
Income from discontinued operations, net
|
1.44
|
|
|
.03
|
|
||
Net income
|
$
|
1.92
|
|
|
$
|
.39
|
|
|
|
|
|
||||
Amounts attributable to Masco Corporation:
|
|
|
|
|
|
||
Income from continuing operations
|
$
|
133
|
|
|
$
|
107
|
|
Income from discontinued operations, net
|
397
|
|
|
9
|
|
||
Net income
|
$
|
530
|
|
|
$
|
116
|
|
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Net income
|
$
|
538
|
|
|
$
|
127
|
|
Less: Net income attributable to noncontrolling interest
|
8
|
|
|
11
|
|
||
Net income attributable to Masco Corporation
|
$
|
530
|
|
|
$
|
116
|
|
Other comprehensive income (loss), net of tax (Note L):
|
|
|
|
|
|
||
Cumulative translation adjustment
|
$
|
(29
|
)
|
|
$
|
(3
|
)
|
Pension and other post-retirement benefits
|
5
|
|
|
4
|
|
||
Other comprehensive (loss) income, net of tax
|
(24
|
)
|
|
1
|
|
||
Less: Other comprehensive loss attributable to noncontrolling interest
|
(4
|
)
|
|
(3
|
)
|
||
Other comprehensive (loss) income attributable to Masco Corporation
|
$
|
(20
|
)
|
|
$
|
4
|
|
Total comprehensive income
|
$
|
514
|
|
|
$
|
128
|
|
Less: Total comprehensive income attributable to noncontrolling interest
|
4
|
|
|
8
|
|
||
Total comprehensive income attributable to Masco Corporation
|
$
|
510
|
|
|
$
|
120
|
|
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
CASH FLOWS FROM (FOR) OPERATING ACTIVITIES:
|
|
|
|
|
|
||
Cash provided by operations
|
$
|
7
|
|
|
$
|
183
|
|
Increase in receivables
|
(183
|
)
|
|
(181
|
)
|
||
Increase in inventories
|
(21
|
)
|
|
(65
|
)
|
||
Increase (decrease) in accounts payable and accrued liabilities, net
|
105
|
|
|
(68
|
)
|
||
Net cash for operating activities
|
(92
|
)
|
|
(131
|
)
|
||
|
|
|
|
||||
CASH FLOWS FROM (FOR) FINANCING ACTIVITIES:
|
|
|
|
|
|
||
Purchase of Company common stock
|
(602
|
)
|
|
(116
|
)
|
||
Proceeds from revolving credit borrowings, net
|
—
|
|
|
87
|
|
||
Cash dividends paid
|
(37
|
)
|
|
(35
|
)
|
||
Proceeds from the exercise of stock options
|
20
|
|
|
9
|
|
||
Employee withholding taxes paid on stock-based compensation
|
(22
|
)
|
|
(14
|
)
|
||
Increase (decrease) in debt, net
|
2
|
|
|
(1
|
)
|
||
Credit Agreement and other financing costs
|
—
|
|
|
(2
|
)
|
||
Net cash for financing activities
|
(639
|
)
|
|
(72
|
)
|
||
|
|
|
|
||||
CASH FLOWS FROM (FOR) INVESTING ACTIVITIES:
|
|
|
|
|
|
||
Capital expenditures
|
(24
|
)
|
|
(38
|
)
|
||
Acquisition of business, net of cash acquired
|
(24
|
)
|
|
—
|
|
||
Proceeds from disposition of:
|
|
|
|
|
|
||
Business, net of cash disposed
|
853
|
|
|
—
|
|
||
Other financial investments
|
1
|
|
|
—
|
|
||
Property and equipment
|
—
|
|
|
5
|
|
||
Other, net
|
1
|
|
|
(5
|
)
|
||
Net cash from (for) investing activities
|
807
|
|
|
(38
|
)
|
||
|
|
|
|
||||
Effect of exchange rate changes on cash and cash investments
|
(6
|
)
|
|
(2
|
)
|
||
|
|
|
|
||||
CASH AND CASH INVESTMENTS:
|
|
|
|
|
|
||
Increase (decrease) for the period
|
70
|
|
|
(243
|
)
|
||
At January 1
|
697
|
|
|
559
|
|
||
At March 31
|
$
|
767
|
|
|
$
|
316
|
|
|
|
Total
|
|
Common
Shares
($1 par value)
|
|
Paid-In
Capital
|
|
Retained (Deficit) Earnings
|
|
Accumulated
Other
Comprehensive
(Loss) Income
|
|
Noncontrolling
Interest
|
||||||||||||
Balance, January 1, 2019
|
$
|
69
|
|
|
$
|
294
|
|
|
$
|
—
|
|
|
$
|
(278
|
)
|
|
$
|
(127
|
)
|
|
$
|
180
|
|
Total comprehensive income
|
128
|
|
|
|
|
|
|
116
|
|
|
4
|
|
|
8
|
|
||||||||
Shares issued
|
5
|
|
|
1
|
|
|
4
|
|
|
|
|
|
|
|
|
||||||||
Shares retired:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Repurchased
|
(122
|
)
|
|
(3
|
)
|
|
(11
|
)
|
|
(108
|
)
|
|
|
|
|
||||||||
Surrendered (non-cash)
|
(10
|
)
|
|
(1
|
)
|
|
|
|
(9
|
)
|
|
|
|
|
|||||||||
Cash dividends declared
|
(35
|
)
|
|
|
|
|
|
(35
|
)
|
|
|
|
|
||||||||||
Stock-based compensation
|
7
|
|
|
|
|
7
|
|
|
|
|
|
|
|
||||||||||
Balance, March 31, 2019
|
$
|
42
|
|
|
$
|
291
|
|
|
$
|
—
|
|
|
$
|
(314
|
)
|
|
$
|
(123
|
)
|
|
$
|
188
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Balance, January 1, 2020
|
$
|
(56
|
)
|
|
$
|
276
|
|
|
$
|
—
|
|
|
$
|
(332
|
)
|
|
$
|
(179
|
)
|
|
$
|
179
|
|
Cumulative effect of adoption of new credit loss standard (refer to Note A)
|
(1
|
)
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
||||||||||
Adjusted balance, January 1, 2020
|
$
|
(57
|
)
|
|
$
|
276
|
|
|
$
|
—
|
|
|
$
|
(333
|
)
|
|
$
|
(179
|
)
|
|
$
|
179
|
|
Total comprehensive income (loss)
|
514
|
|
|
|
|
|
|
530
|
|
|
(20
|
)
|
|
4
|
|
||||||||
Shares issued
|
11
|
|
|
1
|
|
|
10
|
|
|
|
|
|
|
|
|
||||||||
Shares retired:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Repurchased
|
(602
|
)
|
|
(14
|
)
|
|
(28
|
)
|
|
(560
|
)
|
|
|
|
|
||||||||
Surrendered (non-cash)
|
(13
|
)
|
|
|
|
|
|
|
(13
|
)
|
|
|
|
|
|||||||||
Cash dividends declared
|
(36
|
)
|
|
|
|
|
|
(36
|
)
|
|
|
|
|
||||||||||
Stock-based compensation
|
18
|
|
|
|
|
18
|
|
|
|
|
|
|
|
||||||||||
Balance, March 31, 2020
|
$
|
(165
|
)
|
|
$
|
263
|
|
|
$
|
—
|
|
|
$
|
(412
|
)
|
|
$
|
(199
|
)
|
|
$
|
183
|
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Net sales
|
$
|
101
|
|
|
$
|
395
|
|
Cost of sales
|
78
|
|
|
318
|
|
||
Gross profit
|
23
|
|
|
77
|
|
||
Selling, general and administrative expenses
|
32
|
|
|
56
|
|
||
Impairment charge for goodwill (A)
|
—
|
|
|
7
|
|
||
Other income (expense), net
|
—
|
|
|
1
|
|
||
(Loss) income from discontinued operations
|
(9
|
)
|
|
15
|
|
||
Gain on disposal of discontinued operations
|
585
|
|
|
—
|
|
||
Income before income tax
|
576
|
|
|
15
|
|
||
Income tax expense
|
(179
|
)
|
|
(6
|
)
|
||
Income from discontinued operations, net
|
$
|
397
|
|
|
$
|
9
|
|
|
(A)
|
In the first quarter of 2019, we recognized a $7 million non-cash goodwill impairment charge related to a decline in the long-term outlook of our windows and doors business in the United Kingdom.
|
|
December 31, 2019
|
||
Receivables
|
76
|
|
|
Prepaid expenses and other
|
7
|
|
|
Inventories
|
90
|
|
|
Property and equipment, net
|
157
|
|
|
Operating lease right-of-use assets
|
4
|
|
|
Goodwill
|
181
|
|
|
Other intangible assets, net
|
1
|
|
|
Other assets
|
12
|
|
|
Total assets classified as held for sale
|
$
|
528
|
|
|
|
||
Accounts payable
|
$
|
103
|
|
Accrued liabilities
|
46
|
|
|
Noncurrent operating lease liabilities
|
3
|
|
|
Other liabilities
|
10
|
|
|
Total liabilities classified as held for sale
|
$
|
162
|
|
|
Three Months Ended
|
||||||
|
March 31, 2020
|
|
March 31, 2019
|
||||
Depreciation and amortization
|
$
|
—
|
|
|
$
|
9
|
|
Capital expenditures
|
1
|
|
|
11
|
|
||
ROU assets obtained in exchange for new lease obligations
|
—
|
|
|
—
|
|
|
Three Months Ended March 31, 2020
|
||||||||||
|
Plumbing Products
|
|
Decorative Architectural Products
|
|
Total
|
||||||
Primary geographic markets:
|
|
|
|
|
|
||||||
North America
|
$
|
632
|
|
|
$
|
626
|
|
|
$
|
1,258
|
|
International, principally Europe
|
323
|
|
|
—
|
|
|
323
|
|
|||
Total
|
$
|
955
|
|
|
$
|
626
|
|
|
$
|
1,581
|
|
|
Three Months Ended March 31, 2019
|
||||||||||
|
Plumbing Products
|
|
Decorative Architectural Products
|
|
Total
|
||||||
Primary geographic markets:
|
|
|
|
|
|
||||||
North America
|
$
|
598
|
|
|
$
|
573
|
|
|
$
|
1,171
|
|
International, principally Europe
|
342
|
|
|
—
|
|
|
342
|
|
|||
Total
|
$
|
940
|
|
|
$
|
573
|
|
|
$
|
1,513
|
|
|
Three Months Ended
March 31, 2020 |
||
Balance at January 1 (after adopting ASU 2016-13)
|
$
|
5
|
|
Provision for expected credit losses during the period
|
2
|
|
|
Write-offs charged against the allowance
|
(1
|
)
|
|
Recoveries of amounts previously written off
|
1
|
|
|
Balance at end of period
|
$
|
7
|
|
|
Gross Goodwill At March 31, 2020
|
|
Accumulated
Impairment Losses |
|
Net Goodwill At March 31, 2020
|
||||||
Plumbing Products
|
$
|
575
|
|
|
$
|
(340
|
)
|
|
$
|
235
|
|
Decorative Architectural Products
|
358
|
|
|
(75
|
)
|
|
283
|
|
|||
Total
|
$
|
933
|
|
|
$
|
(415
|
)
|
|
$
|
518
|
|
|
Gross Goodwill At December 31, 2019
|
|
Accumulated
Impairment
Losses
|
|
Net Goodwill At December 31, 2019
|
|
Acquisitions
|
|
Other (A)
|
|
Net Goodwill At March 31, 2020
|
||||||||||||
Plumbing Products
|
$
|
566
|
|
|
$
|
(340
|
)
|
|
$
|
226
|
|
|
$
|
12
|
|
|
$
|
(3
|
)
|
|
$
|
235
|
|
Decorative Architectural Products
|
358
|
|
|
(75
|
)
|
|
283
|
|
|
—
|
|
|
—
|
|
|
283
|
|
||||||
Total
|
$
|
924
|
|
|
$
|
(415
|
)
|
|
$
|
509
|
|
|
$
|
12
|
|
|
$
|
(3
|
)
|
|
$
|
518
|
|
|
|
Three Months Ended
March 31, 2020 |
|
Twelve Months Ended December 31, 2019
|
||||
Balance at January 1
|
$
|
84
|
|
|
$
|
81
|
|
Accruals for warranties issued during the period
|
7
|
|
|
34
|
|
||
Accruals related to pre-existing warranties
|
—
|
|
|
1
|
|
||
Settlements made (in cash or kind) during the period
|
(8
|
)
|
|
(31
|
)
|
||
Other, net (including currency translation)
|
(1
|
)
|
|
(1
|
)
|
||
Balance at end of period
|
$
|
82
|
|
|
$
|
84
|
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Long-term stock awards
|
$
|
4
|
|
|
$
|
5
|
|
Stock options
|
3
|
|
|
1
|
|
||
Restricted stock units
|
8
|
|
|
—
|
|
||
Performance restricted stock units
|
1
|
|
|
1
|
|
||
Phantom stock awards and stock appreciation rights
|
—
|
|
|
1
|
|
||
Total
|
$
|
16
|
|
|
$
|
8
|
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Unvested stock award shares at January 1
|
2
|
|
|
2
|
|
||
Weighted average grant date fair value
|
$
|
34
|
|
|
$
|
30
|
|
|
|
|
|
||||
Stock award shares granted
|
—
|
|
|
1
|
|
||
Weighted average grant date fair value
|
$
|
—
|
|
|
$
|
36
|
|
|
|
|
|
||||
Stock award shares vested
|
1
|
|
|
1
|
|
||
Weighted average grant date fair value
|
$
|
32
|
|
|
$
|
24
|
|
|
|
|
|
||||
Stock award shares forfeited
|
—
|
|
|
—
|
|
||
Weighted average grant date fair value
|
$
|
35
|
|
|
$
|
29
|
|
|
|
|
|
||||
Unvested stock award shares at March 31
|
1
|
|
|
2
|
|
||
Weighted average grant date fair value
|
$
|
36
|
|
|
$
|
34
|
|
|
|
Three Months Ended March 31,
|
|||||
|
|
2020
|
|
|
2019
|
||
Option shares outstanding, January 1
|
|
3
|
|
|
|
4
|
|
Weighted average exercise price
|
$
|
27
|
|
|
$
|
21
|
|
|
|
|
|
|
|
||
Option shares granted
|
|
1
|
|
|
|
1
|
|
Weighted average exercise price
|
$
|
48
|
|
|
$
|
36
|
|
|
|
|
|
|
|
||
Option shares exercised
|
|
1
|
|
|
|
1
|
|
Aggregate intrinsic value on date of exercise (A)
|
$
|
22 million
|
|
|
$
|
13 million
|
|
Weighted average exercise price
|
$
|
17
|
|
|
$
|
11
|
|
|
|
|
|
|
|
||
Option shares forfeited
|
|
—
|
|
|
|
—
|
|
Weighted average exercise price
|
$
|
42
|
|
|
$
|
—
|
|
|
|
|
|
|
|
||
Option shares outstanding, March 31
|
|
3
|
|
|
|
4
|
|
Weighted average exercise price
|
$
|
32
|
|
|
$
|
25
|
|
Weighted average remaining option term (in years)
|
|
7
|
|
|
|
6
|
|
|
|
|
|
|
|
||
Option shares vested and expected to vest, March 31
|
|
3
|
|
|
|
4
|
|
Weighted average exercise price
|
$
|
32
|
|
|
$
|
25
|
|
Aggregate intrinsic value (A)
|
$
|
14 million
|
|
|
$
|
57 million
|
|
Weighted average remaining option term (in years)
|
|
7
|
|
|
|
6
|
|
|
|
|
|
|
|
||
Option shares exercisable (vested), March 31
|
|
1
|
|
|
|
2
|
|
Weighted average exercise price
|
$
|
26
|
|
|
$
|
19
|
|
Aggregate intrinsic value (A)
|
$
|
13 million
|
|
|
$
|
50 million
|
|
Weighted average remaining option term (in years)
|
|
6
|
|
|
|
4
|
|
|
(A)
|
Aggregate intrinsic value is calculated using our stock price at each respective date, less the exercise price (grant date price), multiplied by the number of shares.
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Weighted average grant date fair value
|
$
|
10.67
|
|
|
$
|
8.81
|
|
Risk-free interest rate
|
1.53
|
%
|
|
2.57
|
%
|
||
Dividend yield
|
1.14
|
%
|
|
1.35
|
%
|
||
Volatility factor
|
24.00
|
%
|
|
25.00
|
%
|
||
Expected option life
|
6 years
|
|
|
6 years
|
|
|
Three Months Ended March 31,
|
||||||||||||||
|
2020
|
|
2019
|
||||||||||||
|
Qualified
|
|
Non-Qualified
|
|
Qualified
|
|
Non-Qualified
|
||||||||
Service cost
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
—
|
|
Interest cost
|
6
|
|
|
1
|
|
|
10
|
|
|
1
|
|
||||
Expected return on plan assets
|
(6
|
)
|
|
—
|
|
|
(11
|
)
|
|
—
|
|
||||
Amortization of net loss
|
6
|
|
|
1
|
|
|
4
|
|
|
1
|
|
||||
Net periodic pension cost
|
$
|
7
|
|
|
$
|
2
|
|
|
$
|
4
|
|
|
$
|
2
|
|
|
Amounts Reclassified
|
|
|
||||||
Accumulated Other Comprehensive Loss
|
Three Months Ended March 31,
|
|
Statement of Operations Line Item
|
||||||
2020
|
|
2019
|
|
||||||
Amortization of defined-benefit pension and other post-retirement benefits:
|
|
|
|
|
|
|
|
||
Actuarial losses, net
|
$
|
7
|
|
|
$
|
5
|
|
|
Other income (expense), net
|
Tax (benefit)
|
(2
|
)
|
|
(1
|
)
|
|
|
||
Net of tax
|
$
|
5
|
|
|
$
|
4
|
|
|
|
|
Three Months Ended March 31,
|
||||||||||||||
|
2020
|
|
2019
|
|
2020
|
|
2019
|
||||||||
|
Net Sales (A)
|
|
Operating Profit (Loss)
|
||||||||||||
Operations by segment:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Plumbing Products
|
$
|
955
|
|
|
$
|
940
|
|
|
$
|
157
|
|
|
$
|
153
|
|
Decorative Architectural Products
|
626
|
|
|
573
|
|
|
95
|
|
|
73
|
|
||||
Total
|
$
|
1,581
|
|
|
$
|
1,513
|
|
|
$
|
252
|
|
|
$
|
226
|
|
Operations by geographic area:
|
|
|
|
|
|
|
|
||||||||
North America
|
$
|
1,258
|
|
|
$
|
1,171
|
|
|
$
|
210
|
|
|
$
|
181
|
|
International, principally Europe
|
323
|
|
|
342
|
|
|
42
|
|
|
45
|
|
||||
Total
|
$
|
1,581
|
|
|
$
|
1,513
|
|
|
252
|
|
|
226
|
|
||
General corporate expense, net
|
|
|
|
|
(27
|
)
|
|
(29
|
)
|
||||||
Operating profit
|
|
|
|
|
225
|
|
|
197
|
|
||||||
Other income (expense), net
|
|
|
|
|
(51
|
)
|
|
(44
|
)
|
||||||
Income from continuing operations before income taxes
|
|
|
|
|
$
|
174
|
|
|
$
|
153
|
|
|
(A)
|
Inter-segment sales were not material.
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Income from cash and cash investments
|
$
|
1
|
|
|
$
|
1
|
|
Foreign currency transaction losses
|
(9
|
)
|
|
—
|
|
||
Net periodic pension and post-retirement benefit cost
|
(8
|
)
|
|
(5
|
)
|
||
Other items, net
|
—
|
|
|
(1
|
)
|
||
Total other, net
|
$
|
(16
|
)
|
|
$
|
(5
|
)
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Numerator (basic and diluted):
|
|
|
|
|
|
||
Income from continuing operations
|
$
|
133
|
|
|
$
|
107
|
|
Less: Allocation to unvested restricted stock awards
|
1
|
|
|
1
|
|
||
Income from continuing operations attributable to common shareholders
|
132
|
|
|
106
|
|
||
|
|
|
|
||||
Income from discontinued operations, net
|
397
|
|
|
9
|
|
||
Less: Allocation to unvested restricted stock awards
|
3
|
|
|
—
|
|
||
Income from discontinued operations, net attributable to common shareholders
|
394
|
|
|
9
|
|
||
|
|
|
|
||||
Net income attributable to common shareholders
|
$
|
526
|
|
|
$
|
115
|
|
|
|
|
|
||||
Denominator:
|
|
|
|
|
|
||
Basic common shares (based upon weighted average)
|
273
|
|
|
293
|
|
||
Add: Stock option dilution
|
1
|
|
|
1
|
|
||
Diluted common shares
|
274
|
|
|
294
|
|
|
Three Months Ended March 31,
|
|
Percent Change
|
|||||||||
|
2020
|
|
2019
|
|
2020
|
vs.
|
2019
|
|||||
Net Sales:
|
|
|
|
|
|
|
|
|
|
|||
Plumbing Products
|
$
|
955
|
|
|
$
|
940
|
|
|
2
|
%
|
||
Decorative Architectural Products
|
626
|
|
|
573
|
|
|
9
|
%
|
||||
Total
|
$
|
1,581
|
|
|
$
|
1,513
|
|
|
4
|
%
|
||
|
|
|
|
|
|
|||||||
North America
|
$
|
1,258
|
|
|
$
|
1,171
|
|
|
7
|
%
|
||
International, principally Europe
|
323
|
|
|
342
|
|
|
(6
|
)%
|
||||
Total
|
$
|
1,581
|
|
|
$
|
1,513
|
|
|
4
|
%
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Operating Profit (Loss): (A)
|
|
|
|
||||
Plumbing Products
|
$
|
157
|
|
|
$
|
153
|
|
Decorative Architectural Products
|
95
|
|
|
73
|
|
||
Total
|
$
|
252
|
|
|
$
|
226
|
|
|
|
|
|
||||
North America
|
$
|
210
|
|
|
$
|
181
|
|
International, principally Europe
|
42
|
|
|
45
|
|
||
Total
|
252
|
|
|
226
|
|
||
General corporate expense, net
|
(27
|
)
|
|
(29
|
)
|
||
Operating profit
|
$
|
225
|
|
|
$
|
197
|
|
|
|
Three Months Ended March 31,
|
||||||
|
2020
|
|
2019
|
||||
Net sales, as reported
|
$
|
1,581
|
|
|
$
|
1,513
|
|
Acquisitions
|
—
|
|
|
—
|
|
||
Net sales, excluding acquisitions
|
1,581
|
|
|
1,513
|
|
||
Currency translation
|
9
|
|
|
—
|
|
||
Net sales, excluding acquisitions and the effect of currency translation
|
$
|
1,590
|
|
|
$
|
1,513
|
|
MASCO CORPORATION
|
|
Item 4.
|
|
CONTROLS AND PROCEDURES
|
Period
|
Total Number
Of Shares
Purchased
|
|
Average Price
Paid Per
Common Share
|
|
Total Number Of
Shares Purchased
As Part Of
Publicly Announced
Plans or Programs
|
|
Maximum Value Of
Shares That May
Yet Be Purchased
Under The Plans Or Programs
|
||||||
1/1/20 - 1/31/20
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
1,501,539,755
|
|
2/1/20 - 2/29/20 (A)
|
4,752,167
|
|
|
$
|
33.33
|
|
|
4,752,167
|
|
|
$
|
1,343,142,733
|
|
3/1/20 - 3/31/20 (B)
|
9,442,874
|
|
|
$
|
46.94
|
|
|
9,442,874
|
|
|
$
|
899,936,945
|
|
Total for the quarter
|
14,195,041
|
|
|
$
|
42.38
|
|
|
14,195,041
|
|
|
$
|
899,936,945
|
|
|
(A)
|
In November 2019, we entered into an accelerated stock repurchase transaction whereby we agreed to repurchase a total of $400 million of our common stock with an initial delivery of 7.3 million shares. This transaction was completed in February 2020, at which time we received, at no additional cost,1.2 million additional shares of our common stock resulting from changes in the volume weighted average stock price of our common stock over the term of the transaction.
|
(B)
|
In March 2020, we entered into an accelerated stock repurchase transaction whereby we agreed to repurchase a total of $350 million of our common stock with an initial delivery of 7.3 million shares. This transaction will be completed by May 8, 2020, at which time we anticipate we will receive, at no additional cost, approximately 2.3 million additional shares of our common stock resulting from expected changes in the volume weighted average stock price of our common stock over the term of the transaction. The average price paid per common share does not reflect the holdback shares that we expect to receive upon completion of the accelerated stock repurchase transaction. If we had received the expected additional 2.3 million shares at inception of the accelerated stock repurchase transaction, the total number of shares purchased under this transaction would have been approximately 9.6 million with an average price paid per common share of approximately $36.39.
|
|
|
|
|
|
10.a
|
|
|
|
|
|
|
|
10.b
|
|
|
|
|
|
|
|
31a
|
–
|
|
|
|
|
|
|
31b
|
–
|
|
|
|
|
|
|
32
|
–
|
|
|
|
|
|
|
101
|
–
|
The following financial information from Masco Corporation's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, formatted in Inline XBRL: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Consolidated Statements of Shareholders' Equity, and (vi) Notes to Condensed Consolidated Financial Statements.
|
|
|
|
|
|
104
|
–
|
Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
|
|
MASCO CORPORATION
|
|
|
|
|
|
By:
|
/s/ John G. Sznewajs
|
|
Name: John G. Sznewajs
|
|
|
Title: Vice President, Chief Financial Officer
|
•
|
If, prior to the Share Award Date, a Participant retires as an employee of the Company and such retirement occurs on or after the Participant attains (i) age 65, or (ii) age 55 and has at least 10 years of continuous employment with the Company, then, in the discretion of the Committee, the Participant may receive a cash payment equal to the value of a prorated Share Award (where the prorated amount is determined by the Committee and may be based, in part, on the length of the Participant’s service during the Performance Period) that would otherwise have been made. Such cash payment would be made at the same time as Share Awards are made to other Participants; and
|
•
|
If, prior to the Share Award Date, (1) there is a Change in Control of the Company and the Participant is terminated from employment at the time of the Change in Control or within a specified period after the Change in Control (as determined by the Committee) or the Participant resigns from employment for Good Reason (as determined by the Committee) within that specified period, or (2) the Participant dies, or (3) the Participant becomes permanently and totally disabled (as determined by the Committee), then, in the discretion of the Committee, a cash payment equal to the value of a prorated Share Award (where the prorated amount is determined by the Committee and may be based, in part, on the length of the Participant’s service during the Performance Period) that would otherwise have been made. Such cash payment may be made at the same time as Share Awards are made to other Participants.
|
|
Masco Corporation
17450 College Parkway
Livonia, MI 48152
313 274 7400
www.masco.com
|
RE:
|
PRSU Award under the [Insert Performance Period] Program
|
|
Performance Score Percentages
|
|||
|
Weighting
|
Threshold 40%
|
Target 100%
|
Maximum 200%
|
[List Performance Metric(s) and insert the Performance Goal(s)]
|
|
|
|
|
|
|
|
|
|
•
|
You have read and you understand this Award Agreement, the Program and the Plan;
|
•
|
You have received or have access to all of the documents referred to in this Award Agreement;
|
•
|
The terms and conditions contained in the Program, including without limitation, the terms under the caption “Participant’s Further Acknowledgements,” are incorporated into this Award Agreement and are binding on you;
|
•
|
There are no other commitments or understandings currently outstanding with respect to any other grants of options, restricted stock, restricted stock units, phantom stock, stock appreciation rights, or performance awards, except as may be evidenced by other written agreements entered into by you and the Company or the Committee;
|
•
|
You may be required to accept certain terms and conditions at the end of the Performance Period with respect to any Share Award that may be issued to you;
|
•
|
This Award Agreement will be governed by and interpreted in accordance with Michigan law, unless preempted by applicable Federal law; and
|
•
|
This Award is, in all respects, subject to the documents referenced in this Award Agreement and the Committee’s application of its negative discretion, and is intended to comply with, or be exempt from, as the case may be, the provisions of Internal Revenue Code Section 409A.
|
A.
|
On February 18, 2020, Masco divested Masco Cabinetry LLC and on November 6, 2019, Masco divested Milgard Manufacturing Inc. Employee’s affiliation with Masco ended on February 14, 2020 (the “Separation Date”).
|
B.
|
Pursuant to the letter agreement entered into by Masco and Employee on or about June 18, 2019 (the “Retention Agreement”), Employee is eligible for certain Retention Incentives as described therein.
|
C.
|
Employee recognizes that Masco has legitimate business interests that need protection from unfair competition by Employee and that reasonable restraints on Employee’s future activities are necessary in order to protect those interests.
|
D.
|
Employee has had the opportunity to review this Agreement, has been encouraged to consult with legal counsel, if desired, in order to ascertain whether Employee has any potential rights or remedies that will be waived and released upon Employee’s execution of this Agreement.
|
E.
|
Employee and Masco, without any admission of liability, desire to settle with finality, compromise, dispose of, and release all claims and demands of Employee which have been or could be asserted, whether arising out of Employee’s employment, the termination of Employee’s employment, or otherwise.
|
F.
|
Terms not defined herein have the meaning ascribed to them in the Retention Agreement.
|
1.
|
Payment of Retention Incentives. Pursuant to the Retention Agreement, Employee is eligible for the Retention Incentives contained therein. Masco will pay Employee the Retention Incentives consistent with the Retention Letter.
|
2.
|
Employee’s Continuing Obligations.
|
a.
|
Release. Employee, individually, and on behalf of Employee’s heirs, executors, administrators, successors and assigns, releases and forever discharges Masco, Employer, their parents, subsidiaries, affiliates, divisions, and, as to each of the aforementioned, their respective successors, predecessors, assigns, insurers, past and present owners, officers, directors, agents, current and former employees and independent contractors, all others for whom the parties released herein may be vicariously or otherwise liable, the attorneys and legal representatives of all those released herein, as well as the agents and employees of those attorneys and legal representatives, and any and all other persons, firms, companies, corporations and other legal entities (collectively referred to as the “Released Parties”), of and from all claims, demands, actions, causes of action, statutory rights, debts, suits, contracts, agreements, and liabilities of any kind, nature or description, direct or indirect, in law or in equity,
|
b.
|
Medicare Waiver. Employee affirms that as of the date Employee signs this Agreement, (1) Employee is not Medicare eligible (i.e., is not 65 years of age or older; is not suffering from end-stage renal failure; has not received Social Security Disability Insurance benefits for 24 months or longer, etc.) or (2) if eligible, Employee has no outstanding claims for Medicare benefits. Nonetheless, if the Centers for Medicare & Medicaid Services (the “CMS”) (this term includes any related agency representing Medicare’s interests) determines that Medicare has an interest in the payment to Employee under this Agreement, Employee agrees to indemnify, defend and hold Masco harmless from any action by the CMS relating to medical expenses of Employee. Employee agrees to reasonably cooperate with Masco upon request with respect to any claim the CMS may make and for which Employee is required to indemnify Masco under this paragraph.
|
c.
|
Past Agreements Continue. This Agreement does not release Employee of any ongoing obligations owed to the Masco pursuant to the following agreements previously entered into with Masco:
|
i.
|
Dispute Resolution Policy (DRP). Any dispute Employee might have against any Masco, arising out of the terms of this Agreement or otherwise, will be resolved solely by use of Dispute Resolution Policy, the terms of which are incorporated into this Agreement. By signing this Agreement, Employee certifies that Employee has had an opportunity to review the DRP and that Employee has signed an acknowledgement of receipt of that document.
|
ii.
|
Proprietary Confidential Information and Invention Assignment Agreement. Employee agrees to comply with the Proprietary Confidential Information and Invention Assignment Agreement. That Proprietary Confidential Information and Invention Assignment Agreement, a copy of which has been provided to Employee, shall continue in full force and effect. By executing this Agreement, Employee certifies that all confidential, proprietary or trade secret information has been returned as required by Paragraph 2 of the Proprietary Confidential Information and Invention Assignment Agreement.
|
iii.
|
Terms and Conditions of Restricted Stock Awards. Pursuant to the 2014 Masco Corporation Long-Term Stock Incentive Plan, the awards made in letters to you and the related Terms and Conditions of Restricted Stock Awards Granted Under the Masco Corporation 2014 Long Term Stock Incentive Plan, Employee continues to be bound by the obligations described therein.
|
d.
|
Return of Property. Employee agrees to return immediately any and all Masco property still in Employee’s possession (including any and all property of its affiliates) of whatsoever kind and character, including, without limitation, keys, documents, computer software and hardware, discs and media, and policy and procedures manuals.
|
e.
|
Cooperation With Masco. Employee agrees that in the defense or prosecution of any pending or future claim involving Masco or any of its current or former affiliates (collectively referred to as the “Company”), Employee will be available at reasonable times for the purpose of consultation, discovery and providing testimony. Employee will at all times be candid, honest, and forthright in discharging the duties contemplated by this Paragraph. If it becomes necessary for the Company to obtain the cooperation of the Employee as contemplated herein, the Company will, in good faith and to the extent practicable, endeavor to reasonably accommodate the Employee’s personal and work schedules and reimburse reasonable expenses incurred by the Employee in connection with providing support and cooperation pursuant to this Agreement.
|
f.
|
Non-Cooperation With Others. Except to the extent permitted by applicable law, Employee shall not encourage or, except as required by law, provide any information about the business, products, or employees of the Company to any person or entity to assert, maintain, or prosecute a claim or litigation against Company or its officers, directors, or employees. Employee further agrees that, if approached informally or subpoenaed by any person, company, attorney, or agent for any person or entity other than the Company, at any time regarding any matter, currently litigated or otherwise, involving the Company, its employees, its products, or its business, Employee will give immediate notice to the General Counsel of Masco Corporation, 17450 College Parkway, Livonia, MI 48152. Masco shall reimburse Employee for any reasonable expense incurred in connection with such notification.
|
g.
|
No Disparagement. Employee agrees not to criticize, disparage or otherwise demean in any way Masco or its affiliates or their respective products, officers, directors or employees. This includes, but is not limited to, directly or indirectly providing disparaging comments to the media or disseminating them electronically, such as on any website or blog.
|
h.
|
Non-Disclosure. Employee agrees that the negotiations concerning this Agreement, the fact of this Agreement, and the contents of this Agreement shall be kept strictly confidential, and shall not be disclosed to any person. Notwithstanding the above, Employee may disclose the terms of this Agreement: (a) to Employee’s spouse, tax advisors, taxing authorities and attorneys; (b) as may be required in response to a court order or subpoena; (c) as may be required by law or financial institutions with which Employee does business; or (e) in any action alleging a breach of, or seeking to enforce, this Agreement. To the extent the existence or the terms of the Agreement are revealed pursuant to this paragraph, Employee agrees to take reasonable steps to ensure that any information which is disclosed will not be disclosed to any other third party, including, but not limited to, by advising such recipients that they must not divulge the terms of this Agreement and that the terms are considered confidential.
|
i.
|
Disclosure of Known Claims. Employee represents and warrants that Employee has disclosed to Masco any and all facts within Employee’s knowledge concerning any actual or potential claim against Masco, including but not limited to any and all claims arising out of federal, state or local law, or any claim resulting in or from a loss, theft or fraud against Masco.
|
j.
|
No Actions Filed. Employee represents that Employee has not filed any action, charge, suit, or claim against Masco with any federal, state, or local agency or court, and has not initiated any mediation or arbitration proceeding. Employee further agrees that Employee shall not receive or be entitled to any monetary damages, recovery, and/or relief of any type in connection with any charge, administrative action, or legal proceeding pursued by Employee, by any governmental agency, person, group, or entity regarding and/or relating to any claim(s) released pursuant to this Agreement.
|
k.
|
Consequence of Employee’s Breach. Employee acknowledges and agrees that if Employee, in Masco’s good faith judgment, breaches any obligation under this Agreement or the Retention Agreement, Masco may immediately terminate any remaining payments and the provision of any other benefits that might otherwise be required by this Agreement; provided, however, Employee will be paid or allowed to retain $1,000 of the Retention Incentives. Any such termination by Masco shall not impair the validity or enforceability of the release provision of this Agreement.
|
l.
|
Additional Relief. The Employee acknowledges and agrees that Masco’s remedy at law for a breach or threatened breach of any of the following provisions of this Agreement: Disclosure of Known Claims, Non-Competition, No Disparagement, Non-Disclosure, Proprietary Confidential Information and Invention Assignment Agreement, Cooperation with Masco, Non-Cooperation with Others - would be inadequate and, in recognition of this fact, in the event of a breach or threatened breach of any of these provisions, the Employee agrees that, in addition to its remedy at law, and at Masco’s option, all rights of the Employee under Paragraph 1 of this Agreement may be terminated, and Masco shall be entitled without posting any bond to obtain, and the Employee agrees not to oppose a request for, equitable relief in the form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available. The Employee acknowledges that the granting of a temporary injunction, temporary restraining order or permanent injunction merely prohibiting the use of Proprietary Information would not be an adequate remedy upon breach or threatened breach hereof, and consequently agrees upon any such breach or threatened breach to the granting of injunctive relief prohibiting the design, development, manufacture, marketing or sale of products and providing of services of the kind designed, developed, manufactured, marketed, sold or provided by Masco or its affiliates as of the date of this Agreement. Nothing herein contained shall be construed as prohibiting Masco from pursuing, in addition, any other remedies available to it for such breach or threatened breach.
|
m.
|
Remedies Cumulative. Employee acknowledges and agrees that the rights and remedies given to Masco in this Agreement shall be deemed cumulative, and the exercise of one such remedy shall not operate to bar the exercise of any other rights and remedies reserved to Masco or available at law or in equity.
|
n.
|
Employee Acknowledgments. Employee specifically represents, warrants and confirms that Employee: (a) has been properly paid for all hours worked for the Employer; (b) has received all bonuses and other compensation due to the Employee with the exception of the Employee’s final payroll check(s) for wages through and including the Separation Date, which will be paid at the time of separation; (c) is not entitled to any bonuses or other compensation; and (d) has not engaged in any unlawful conduct relating to the business of Masco.
|
3.
|
Miscellaneous Provisions
|
a.
|
Termination of Welfare Benefit and Pension Plans. As of the Separation Date, Employee shall cease to be an active participant under Masco’s welfare benefit and pension plans (or the plans of any of Masco’s affiliates) pursuant to the terms of those plans, and no additional benefits shall accrue to Employee. Employee waives any claim to such accrual of benefits beyond the Separation Date.
|
b.
|
Time for Acceptance. Employee has twenty-one days during which to consider this offer. Employee is not required to, but may, accept this Agreement by signing and dating it within twenty-one days. If Employee does not execute this Agreement within twenty-one days, then Masco’s offer of this Agreement will be revoked and it shall be deemed null and void.
|
c.
|
Revocation/ Effective Date. Employee understands that Employee may revoke this Agreement for a period of seven calendar days following the execution of this Agreement. Therefore, the Effective Date of this Agreement will be the eighth calendar day after Employee signs and dates the Agreement. Employee further understands that, to be effective, any revocation must be in writing and postmarked within seven calendar days of the date on which Employee signs and dates this Agreement, and that the revocation notice must be addressed to Tara Mahoney, Corporate Employment Counsel, Masco Corporation, 17450 College Parkway, Livonia, MI 48152. If revocation is by mail, Employee should send it by certified mail, return receipt requested in order to create proof of mailing.
|
d.
|
Withholding and Payroll Taxes. Any and all payments to Employee under this Agreement are subject to applicable withholding and payroll taxes.
|
e.
|
Applicable Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Michigan.
|
f.
|
Venue. The parties agree that any dispute may only be commenced in the office of the American Arbitration Association nearest Livonia, Michigan.
|
g.
|
Entire Agreement. This Agreement contains the parties’ entire agreement relating to its subject matter and supersedes and replaces all other agreements and/or understandings between the parties relating to its subject matter, except as otherwise specifically stated herein; provided however, that the Retention Agreement, Proprietary Confidential Information and Invention Assignment Agreement and the Dispute Resolution Policy referenced herein shall be incorporated by reference into this Agreement and shall continue in full force and effect, as shall those terms in any and all other agreements which, by their terms survive the termination of employment.
|
h.
|
Modifications. This Agreement may not be modified except by a subsequent written agreement, executed by both parties, which specifically evidences an intent to modify the terms of this Agreement. Employee reaffirms Employee’s agreement to comply with all such ongoing obligations. The terms of this Agreement are contractual and not a mere recital.
|
i.
|
No Oral Representations. Employee represents that no promise, inducement or agreement has been made between the parties regarding the subject matter of this agreement other than those specifically set forth in this Agreement, and that he has not relied on any oral statements of Masco or its representatives in deciding to sign this Agreement.
|
j.
|
Knowing and Voluntary. Employee represents that employee fully understands the terms of this Agreement, and is executing this Agreement voluntarily.
|
k.
|
Severability. If any portion of this Agreement is ruled unenforceable, all remaining provisions shall remain valid and in effect.
|
l.
|
Waiver of Breach. The waiver by Masco of any breach of any provision of this Agreement shall not be construed or considered as a waiver of any subsequent breach.
|
m.
|
Headings. The headings of each Paragraph are for convenience only, and shall not affect the meaning or intent of any provision of this Agreement.
|
n.
|
Assignment. Employee’s obligations under this Agreement are not assignable, although Masco shall have the right to assign this Agreement. This Agreement shall be binding upon Employee’s executors, heirs, estate, legal representatives, beneficiaries, and other successors in interest and shall inure to the benefit of Masco and its successors and assigns. All subsidiaries, affiliates, and successors in interest of or to Masco are intended to be third party beneficiaries of this Agreement.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Masco Corporation ("the registrant");
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
April 29, 2020
|
|
By:
|
/s/ Keith J. Allman
|
|
|
|
|
Keith J. Allman
|
|
|
|
|
President and Chief Executive Officer
|
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Masco Corporation ("the registrant");
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
April 29, 2020
|
|
By:
|
/s/ John G. Sznewajs
|
|
|
|
|
John G. Sznewajs
|
|
|
|
|
Vice President, Chief Financial Officer
|
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of Masco Corporation.
|
Date:
|
|
April 29, 2020
|
|
/s/ Keith J. Allman
|
|
|
|
|
Keith J. Allman
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
|
Date:
|
|
April 29, 2020
|
|
/s/ John G. Sznewajs
|
|
|
|
|
John G. Sznewajs
|
|
|
|
|
Vice President, Chief Financial Officer
|
|